Edgewise Therapeutics, Inc.

NASDAQ:EWTX

Biotechnology

Healthcare
$41.37 +3.19%

+$1.11 today

Market cap
$4.45B
Beta
0.30
P/E (TTM)
-21.9
EPS (TTM)
-$1.64
52W Low $12.15High $40.77

Volume 0.87M

Average 1.32M

EWTX Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

No reported Gross Margin figures are available to summarize.

Gross Margin history

Percent of revenue · from the income statement

No Gross Margin data reported for this period type.

Gross Margin vs competitors

How EWTX compares with its peers on the latest reported figures

EWTX Competitors Peer median
Gross Margin for EWTX and competitors
Company Period LTM level YoY 3-year change
STOKStoke Therapeutics, Inc.LTM Mar 202690.4% -9.1 pp+0.0 pp
PTCTPTC Therapeutics, Inc.LTM Jun 202682.1% -14.9 pp+2.2 pp
SRPTSarepta Therapeutics, Inc.LTM Mar 202662.4% -19.4 pp-25.1 pp
TRDAEntrada Therapeutics, Inc.LTM Mar 2026-598.0% -698.0 pp—
EWTXEdgewise Therapeutics, Inc.FY2025— ——
DYNDyne Therapeutics, Inc.FY2025— ——
SLDBSolid Biosciences Inc.FY2025— ——
CAPRCapricor Therapeutics, Inc.FY2025— ——
LRMRLarimar Therapeutics, Inc.FY2025— ——
PEPGPepGen Inc.FY2025— ——
Peer median (excluding EWTX) 72.3%-17.2 pp+0.0 pp

Competitors are the stored peer set for EWTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00002.27M
Gross Profit0000(2.27M)
Gross Margin—————
Research & Development32.19M54.03M90.91M126.97M151.39M
Selling, General & Admin11.03M17.63M23.45M31.87M40.02M
Operating Expenses43.22M71.66M114.36M158.83M189.14M
Depreciation & Amortization272K538K1.73M2.29M2.27M
EBITDA(42.54M)(63.08M)(98.43M)(131.52M)(165.53M)
EBITDA Margin—————
Operating Income(43.22M)(71.66M)(114.36M)(158.83M)(191.41M)
Operating Margin—————
Interest Income402K2.66M14.19M25.02M23.61M
Interest Expense04.02M000
Other Income / Expenses402K4.02M14.19M25.02M23.61M
Income Before Tax(42.81M)(67.64M)(100.16M)(133.81M)(167.8M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(42.81M)(67.64M)(100.16M)(133.81M)(167.8M)
Net Margin—————
EPS (Basic)(0.86)(1.26)(1.57)(1.45)(1.63)
EPS (Diluted)(0.86)(1.26)(1.57)(1.45)(1.63)
Weighted Avg Shares49.5M53.59M63.72M92.41M102.93M
Weighted Avg Shares (Diluted)49.5M53.59M63.72M92.41M102.93M

Edgewise Therapeutics, Inc.

NASDAQ:EWTX

Intrinsic Alpha fair value

Locked

Current Price

$41.37

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.